Table 2 Association of IFI16 expression with the clinicopathological characteristics of patients with LSCC
Variable | All patients | IFI16 protein | P-value | |||
|---|---|---|---|---|---|---|
− | + | ++ | +++ | |||
Age at surgery | P = 0.611 > 0.05 | |||||
 <60 | 17 | 0 | 7 | 3 | 7 | |
 ≥ 60 | 19 | 0 | 8 | 6 | 5 | |
Sex | P = 0.826 > 0.05 | |||||
 Male | 31 | 0 | 13 | 8 | 10 | |
 Female | 5 | 0 | 2 | 1 | 2 | |
Histological grade | P = 0.003 < 0.05 | |||||
 I (well) | 10 | 0 | 0 | 3 | 7 | |
 II (moderate) | 25 | 0 | 15 | 5 | 5 | |
 III (poor) | 1 | 0 | 0 | 1 | 0 | |
Tumor stage | P = 0.127 > 0.05 | |||||
 T status | ||||||
  T1/T2 | 28 | 0 | 10 | 7 | 11 | |
  T3/T4 | 8 | 0 | 5 | 2 | 1 | |
 N status | P = 0.107 > 0.05 | |||||
  N0 | 32 | 0 | 12 | 8 | 12 | |
  N1/N2/N3 | 4 | 0 | 3 | 1 | 0 | |
 M status |  | |||||
  M0 | 36 | 0 | 15 | 9 | 12 |  |
  M1 | 0 | 0 | 0 | 0 | 0 |  |